Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution Experience.

Karachaliou, Georgia Sofia

Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution Experience. [electronic resource] - Oncology 2020 - 174-178 p. digital

Publication Type: News

1423-0232

10.1159/000504578 doi


Academic Medical Centers
Adult
Aged
Antineoplastic Agents, Alkylating--adverse effects
Antineoplastic Agents, Immunological--adverse effects
Disease Progression
Female
Humans
Male
Melanoma--drug therapy
Middle Aged
Neoplasm Staging
North Carolina
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Progression-Free Survival
Retrospective Studies
Risk Factors
Skin Neoplasms--drug therapy
Temozolomide--adverse effects
Time Factors